| Sans Bois Health Services | |
| 901 East Main Street, Suite C, Stigler, Oklahoma 74462 | |
| (918) 967-1001 | |
| Not Available |
| Name | Sans Bois Health Services |
|---|---|
| Location | 901 East Main Street, Suite C, Stigler, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377635 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 74941 |
| NPI Number | 1104887108 |
| Organization Name | SANS BOIS HEALTH SERVICES, INC. |
| Address | 1505 E Main St Ste C, Stigler, OK 74462 |
| Phone Number | 918-967-1001 |
News Archive
Trial lawyers and consumer advocates are trotting out a novel argument as they fight off tort reform proposals: they say medical malpractice suits, rather than driving over-use of costly tests by risk-averse doctors, instead prevent rationing.
Teva Pharmaceutical Industries Ltd. announces the launch of the authorized generic of Provigil (modafinil).
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
The United States Food and Drug Administration recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
› Verified 6 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
Trial lawyers and consumer advocates are trotting out a novel argument as they fight off tort reform proposals: they say medical malpractice suits, rather than driving over-use of costly tests by risk-averse doctors, instead prevent rationing.
Teva Pharmaceutical Industries Ltd. announces the launch of the authorized generic of Provigil (modafinil).
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
The United States Food and Drug Administration recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
› Verified 6 days ago
News Archive
Trial lawyers and consumer advocates are trotting out a novel argument as they fight off tort reform proposals: they say medical malpractice suits, rather than driving over-use of costly tests by risk-averse doctors, instead prevent rationing.
Teva Pharmaceutical Industries Ltd. announces the launch of the authorized generic of Provigil (modafinil).
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
The United States Food and Drug Administration recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically indicated for BED.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
› Verified 6 days ago
Healthback Home Health Of Stigler Location: 111 North Broadway Street, Stigler, Oklahoma 74462 Ratings: Phone: (405) 842-1700 | |
Complete Home Health Of Stigler Location: 205 East Main Street, Stigler, Oklahoma 74462 Ratings: Phone: (918) 967-9443 | |
Sans Bois Health Services Location: 901 East Main Street, Suite C, Stigler, Oklahoma 74462 Ratings: NA Phone: (918) 967-1001 | |
Compassion Home Care, Inc Location: 901 East Main Street, Suite D, Stigler, Oklahoma 74462 Ratings: Phone: (918) 967-1003 | |
Platinum Healthcare, Inc Location: 1304 Nw 7th Street, Stigler, Oklahoma 74462 Ratings: NA Phone: (918) 967-9313 | |
Oldham Home Care Llc Location: 519 East Main Street, Stigler, Oklahoma 74462 Ratings: Phone: (918) 967-9971 |